Tag: #Global Trends

Key Development American biotechnology pioneer Moderna, Inc. (NASDAQ: MRNA) officially released its Q2 2026 financial results, exceeding Wall Street consensus... Read more

Key Development Basel-based generics and biosimilars leader Sandoz Group AG has formally entered into definitive settlement agreements to resolve long-standing... Read more

Key Development Following a challenging two-year period marked by profit warnings, executive restructuring, and share price contraction, Novo Nordisk is... Read more

Key Development Sanofi has upgraded its 2026 sales outlook to approximately 10% growth at constant exchange rates, above its previous... Read more

Key Development Healthcare Triangle has completed the issuance of 12,546,540 common shares to satisfy consideration for two previously approved acquisitions,... Read more

Key Development CSL has announced that it will begin clinical studies to support regulatory approval of Horizon 2, its proprietary... Read more

Key Development GSK reported stronger-than-expected second quarter earnings while unveiling a US$2.52 billion restructuring programme designed to generate £1.9 billion... Read more

Key Development A US federal judge has allowed part of a shareholder lawsuit against Novo Nordisk to proceed. The surviving... Read more

Key Development Environmental health has become an increasingly important issue for industries operating in resource-rich regions. Recent allegations linking oil... Read more